Bibliografía Guía para la Vitamina D3

1. Berk M, Jacka FN, Williams LJ, Ng F, Dodd S, Pasco JA. Is thisD vitamin to worry about? Vitamin D insufficiency in an inpatientsample. Aust N Z J Psychiatry 2008; 42:874 – 878.

2. GuishengZhao& Robert U. Simpson, Membranelocalization, Caveolin-3 association and rapidactions of vitamin D receptor in cardiacmyocytes. Steroids 75 (2010) 555–559

3. Park S, Johnson M. Living in low-latitude regions in the United States does not prevent poor vitamin D status. NutrRev2005;63:203 – 209.

4. Morelli S, Buitrago C, Boland R, de Boland AR. Thestimulation of MAP kinaseby 1,25(OH)(2)-vitamin D(3) in skeletalmusclecellsismediatedbyproteinkinase C and calcium. Mol CellEndocrinol 2001;173:41–52.

5. Maurice Audran&KarineBriotCriticalreappraisal of vitamin D deficiency. JointBoneSpine 77 (2010) 115–119.

6. Heaney RP, Dowell MS, Hale CA, et al. Calciumabsorptionvarieswithinthereferencerange forserum25-hydroxyvitamin D. J Am CollNutr 2003; 22(2):142–6.

7. Neil Binkley, RekhaRamamurthy& Diane Krueger, LowVitamin D Status: Definition, Prevalence, Consequences and Correction. EndocrinolMetabClin N Am 39 (2010) 287–301.

8. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D onfalls: a meta-analysis. JAMA 2004;291:1999–2006.

9. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:170–3.

10. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J ClinNutr 1999;69:842–56.

11. SimoneMocellinVitamin D and cancer: Decipheringthetruth. Biochimica et Biophysica Acta 1816 (2011) 172–178.

12. Vitamin D receptor (VDR)-mediatedactions of 1a,25(OH)2vitamin D3: Genomic and non-genomicmechanisms. Mark R. Haussler, RegentsProfessor ,PeterW. Jurutka, Mathew Mizwicki& Anthony W. Norman. BestPractice&ResearchClinicalEndocrinology&Metabolism 25 (2011) 543–559